pfizer to appeal loss of celebrex patent
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice
Emiratesvoice, emirates voice
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice

Pfizer to appeal loss of Celebrex patent

Emiratesvoice, emirates voice

Emiratesvoice, emirates voice Pfizer to appeal loss of Celebrex patent

New York - AFP

Human Rights Minister Horriah Mashhor met here on Wednesday with Bishow Parajuli, Representative and Country Director of the United Nations World Food Programme (WFP) in Yemen.Pharmaceutical giant Pfizer said on Wednesday it will appeal a US federal court's refusal to extend patent protection for its blockbuster Celebrex drug used to treat arthritis. Pfizer said the US District Court for the Eastern District of Virginia invalidated the reissue patent covering methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex. The ruling means that Pfizer will be exposed to competition from generic drug makers earlier than the company expected. "Pfizer disagrees with the ruling and will pursue all available remedies, including an immediate appeal of the court's decision," the world's largest pharmaceutical company said in a statement. Celebrex generated about $800 million in sales in the fourth quarter of 2013. On Wall Street,  Dow member Pfizer finished at $31.98, shedding 1.percent. Earlier in the day, trade in the shares was briefly suspended. The judge knocked down a patent reissue obtained by Pfizer on March 5. The reissue of the patent would have protected the Pfizer's celecoxib from competition until December 2, 2015. Pfizer has filed suit against several generic drug makers for infringement of the reissue patent. The companies had sought US government approval to market a generic form of celecoxib in the United States beginning on May 30, when Pfizer's basic patent expires. The defendants in that case are Israel's Teva, the world's largest generic drug maker; US firms Mylan Pharmaceuticals and Watson Laboratories; Canadian firm Apotex and India's Lupin. The trial was scheduled to begin on March 19. At their meeting, Mashhor reviewed tasks and efforts of the ministry in promoting and protecting human rights, noting to the output of the national dialogue related to the rights and freedoms, in addition to the ministry's action in the development and embodiment of those outputs with national and international partners. For his part, Parajuli pointed out to increasing the WFP supportt for Yemen in fields of education of girls, displaced persons and reduction of child labor. The WFP sponsors a meeting of Promoting Human Rights group through highlighting the national dialogue outputs along with the ministry, as well as recommendations of the periodic report, which was discussed in the Human Rights Council in Geneva in January.

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

pfizer to appeal loss of celebrex patent pfizer to appeal loss of celebrex patent

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

pfizer to appeal loss of celebrex patent pfizer to appeal loss of celebrex patent

 



GMT 09:58 2016 Wednesday ,23 March

cartoon four

GMT 10:16 2016 Wednesday ,23 March

cartoon five

GMT 05:06 2024 Tuesday ,06 February

New hunt for flight MH370 gets under way

GMT 08:25 2017 Monday ,06 November

Mohamed considers new drama and cinema offers

GMT 21:02 2017 Monday ,20 March

SCZone studying to establish SME complex

GMT 07:48 2011 Thursday ,15 September

S. Korea, Colombia to Jointly Develop Oil Fields

GMT 08:53 2016 Saturday ,26 November

Timeline of Fidel Castro's life whose death at 90

GMT 14:15 2017 Thursday ,23 February

Nike sports ad sparks controversy in Arab world

GMT 07:44 2017 Sunday ,17 December

Ahmed Mortada denies negotiations

GMT 08:58 2017 Thursday ,23 November

A visionary electric hypercar

GMT 22:21 2017 Monday ,27 November

Here's how you can vote for your Miss Universe

GMT 15:08 2017 Wednesday ,13 December

Unmatched sacrifices of security forces to be remembered
 
 Emirates Voice Facebook,emirates voice facebook  Emirates Voice Twitter,emirates voice twitter Emirates Voice Rss,emirates voice rss  Emirates Voice Youtube,emirates voice youtube  Emirates Voice Youtube,emirates voice youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

emiratesvoieen emiratesvoiceen emiratesvoiceen emiratesvoiceen
emiratesvoice emiratesvoice emiratesvoice
emiratesvoice
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
emiratesvoice, Emiratesvoice, Emiratesvoice